Nephro Care India (NSE:NEPHROCARE) Notes Receivable: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NEPHROCARE Nephro Care India Ltd NSE:NEPHROCARE
48 GF Score
Price ₹93.75
! 2 Warning Signs
View Full Analysis

What is Nephro Care India Notes Receivable?

Nephro Care India NSE:NEPHROCARE +2.29% 48 Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review.

Nephro Care India's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Nephro Care India Notes Receivable Related Terms

Nephro Care India Notes Receivable Historical Data

* Premium members only.

The historical data trend for Nephro Care India's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephro Care India Notes Receivable Chart

Nephro Care India Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nephro Care India Semi-Annual Data
Mar21 Mar22 Mar23 Dec23 Mar24 Sep24 Mar25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:NEPHROCARE
48GF Score
Nephro Care India Ltd NSE:NEPHROCARE
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nephro Care India Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Nephro Care India (NSE:NEPHROCARE) has a Notes Receivable of ₹0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Nephro Care India and its competitors.
Is Nephro Care India's Notes Receivable too high?
Nephro Care India's current Notes Receivable is ₹0.0 Mil. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's Notes Receivable compare to HCA and THC?
Nephro Care India's Notes Receivable of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Nephro Care India and its competitors. Nephro Care India's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nephro Care India Business Description

Address c/o EFC India - Millenium City IT Park, Tower 2, 12th Floor, DN 62, DN Block, Sector V, Bidhannagar, Kolkata, WB, IND, 700091
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score

Get the complete analysis for NSE:NEPHROCARE

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹93.75
Price